San Fran­cis­co biotech has its heart in heart fail­ure — and $92M in the bank

When a sala­man­der’s heart suf­fers dam­age, the am­phib­ian’s cells are able to di­vide and re­pair the or­gan. Tenaya Ther­a­peu­tics wants to em­pow­er your heart with the same abil­i­ty.

The South San Fran­cis­co-based com­pa­ny, found­ed by sci­en­tists at the Glad­stone In­sti­tutes and Uni­ver­si­ty of Texas South­west­ern Med­ical Cen­ter in Oc­to­ber 2016, has a mul­ti-lay­ered ap­proach to ad­dress­ing trou­bles of the heart — cel­lu­lar re­gen­er­a­tion, gene ther­a­py, and pre­ci­sion med­i­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER